Thomas A. Abrams
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
Papers in
- Oncology 49
- Colorectal Cancer Treatments and Studies 25
- Pancreatic and Hepatic Oncology Research 11
-
- Gastric Cancer Management and Outcomes 12
- Lung Cancer Treatments and Mutations 11
- Co-authors
- Charles S. Fuchs (36 shared papers)Jeffrey A. Meyerhardt (29 shared papers)Andrew X. Zhu (23 shared papers)Lawrence S. Blaszkowsky (26 shared papers)David P. Ryan (19 shared papers)Peter C. Enzinger (24 shared papers)Jeffrey W. Clark (9 shared papers)Brian M. Wolpin (26 shared papers)
- Journals
- Journal of Clinical Oncology (46 papers)Annals of Oncology (5 papers)Clinical Cancer Research (4 papers)Investigational New Drugs (4 papers)The Oncologist (4 papers)
- Partner nations
- United StatesCanadaFrance
In The Last Decade
Thomas A. Abrams
84 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 95
- Hepatology 500
- Oncology 1.2k
- Cancer Research 350
- Pathology and Forensic Medicine 384
- Pulmonary and Respiratory Medicine 511
Countries citing papers authored by Thomas A. Abrams
This map shows the geographic impact of Thomas A. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Abrams more than expected).
Fields of papers citing papers by Thomas A. Abrams
This network shows the impact of papers produced by Thomas A. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Abrams. The network helps show where Thomas A. Abrams may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas A. Abrams, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 356 | |
| 2 | 2008 | 249 | |
| 3 | 2009 | 230 | |
| 4 | 2011 | 163 | |
| 5 | 2013 | 157 | |
| 6 | 2014 | 122 | |
| 7 | 2017 | 96 | |
| 8 | 2011 | 84 | |
| 9 | 2014 | 82 | |
| 10 | 2010 | 76 | |
| 11 | 2017 | 75 | |
| 12 | 2011 | 67 | |
| 13 | 2020 | 61 | |
| 14 | 2013 | 58 | |
| 15 | 2018 | 56 | |
| 16 | 2013 | 53 | |
| 17 | 2011 | 49 | |
| 18 | 2020 | 46 | |
| 19 | 2013 | 42 | |
| 20 | 2014 | 42 |
About Thomas A. Abrams
Thomas A. Abrams is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Hepatology and Molecular Biology, having authored 87 papers that have together received 2.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (25 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Gastric Cancer Management and Outcomes (12 papers), Pancreatic and Hepatic Oncology Research (11 papers), Lung Cancer Treatments and Mutations (11 papers), Neuroblastoma Research and Treatments (5 papers) and Fibroblast Growth Factor Research (5 papers). The work is most often cited by research in Hepatology (500 citations), Oncology (1.2k citations), Cancer Research (350 citations), Pathology and Forensic Medicine (384 citations) and Pulmonary and Respiratory Medicine (511 citations). Thomas A. Abrams has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Charles S. Fuchs, Jeffrey A. Meyerhardt, Andrew X. Zhu, Lawrence S. Blaszkowsky, David P. Ryan, Peter C. Enzinger, Jeffrey W. Clark, Brian M. Wolpin, Deborah Schrag and Eunice L. Kwak. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research, Investigational New Drugs and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.